Atrium Therapeutics Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Atrium Therapeutics Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- RNA
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0002093101
Board of directors
-
Carsten Boess · DirectorSince 2026
-
Kathleen P. Gallagher · Director · See RemarksSince 2026
-
Sarah Boyce · DirectorSince 2026
-
Simona Skerjanec · DirectorSince 2026
-
Troy Edward Wilson · DirectorSince 2026
-
W. Michael Flanagan · DirectorSince 2026
Board connections
4 of this board's directors also sit on 6 other boards.
- via Sarah Boyce
- via Simona Skerjanec
- via Troy Edward Wilson
- via Sarah Boyce
- via Troy Edward Wilson
- via Carsten Boess
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 18, 2026 | Hoyos Rocio Martin Officer (Chief Strategy Officer) | Shares withheld for tax | −8,320 | $8.95 | $74,464 |
| Sep 18, 2026 | Winslow Brendan R. Officer (Chief Financial Officer) | Shares withheld for tax | −6,742 | $8.95 | $60,341 |
| Sep 18, 2026 | Kathleen P. Gallagher Director, Officer (See Remarks) | Shares withheld for tax | −11,632 | $8.95 | $104,106 |
| Sep 18, 2026 | Kenney Stephanie Officer (See Remarks) | Shares withheld for tax | −2,375 | $8.95 | $21,256 |
| Sep 18, 2026 | Sarah Boyce Director | Shares withheld for tax | −126,418 | $8.95 | $1,131,441 |
| Sep 18, 2026 | W. Michael Flanagan Director | Shares withheld for tax | −22,812 | $8.95 | $204,167 |
| Sep 18, 2026 | Hughes Steven George Officer (Chief Medical Officer) | Shares withheld for tax | −21,459 | $8.95 | $192,058 |
| Sep 18, 2026 | Younis Husam Officer (Chief Scientific Officer) | Shares withheld for tax | −11,216 | $8.95 | $100,383 |
| Apr 20, 2026 | Kenney Stephanie Officer (See Remarks) | Grant or award | +30,000 | — | — |
| Apr 20, 2026 | Hughes Steven George Officer (Chief Medical Officer) | Grant or award | +30,000 | — | — |
| Apr 20, 2026 | Winslow Brendan R. Officer (Chief Financial Officer) | Grant or award | +30,000 | — | — |
| Apr 20, 2026 | Kathleen P. Gallagher Director, Officer (See Remarks) | Grant or award | +102,500 | — | — |
| Apr 20, 2026 | Hoyos Rocio Martin Officer (Chief Strategy Officer) | Grant or award | +30,000 | — | — |
| Apr 20, 2026 | Younis Husam Officer (Chief Scientific Officer) | Grant or award | +30,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.